Self-Medication, Bipolar Disorders, and Stimulant Dependence
J Clin Psychiatry 2009;70(6):935-936
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Sir: In the August 2008 issue of the Journal, Nejtek et
al. present findings that both quetiapine and risperidone
produced improvement in manic, mixed, and depressive symptoms.
In turn, symptom reduction was associated with reduced
drug cravings in patients with co-occurring bipolar and stimulant
dependence disorders, albeit not affecting drug use. These
are important findings in that (1) there is an extraordinarily
high incidence of co-occurrence of substance abuse in general
associated with bipolar disorders and, in particular, a high cooccurrence
of stimulant abuse; and (2) there are few if any specific
effective psychopharmacologic treatments for stimulant dependence.